ProSci

Executive Summary

ProSci, founded in 1998 and based in Poway, California, is a well-established supplier of high-quality recombinant proteins and antibodies to the global life sciences research community. The company serves academic, pharmaceutical, and diagnostic laboratories, providing essential reagents for basic research, assay development, and diagnostic applications. With over two decades of experience, ProSci has built a reputation for reliability and quality in the competitive antibodies and proteins market. As a key player in the life science tools sector, the company benefits from steady demand driven by ongoing research and development activities worldwide. While ProSci operates in a mature market with moderate growth, its established customer base and focus on quality position it for continued stability. However, the company's lack of disclosed financials or recent funding rounds suggests a private, low-profile operation with limited near-term expansion catalysts beyond organic growth.

Upcoming Catalysts (preview)

• Q4 2026Launch of novel recombinant antibody platform60% success
• Q1 2027Strategic partnership with major pharmaceutical company for assay development40% success
• Q2 2027Expansion into diagnostic antibody market with IVD-grade products50% success